Technical Support

The basis of this technology was developed by a team of researchers led by physicians from Taipei Medical University, including a French doctor. The technology was then transferred to our company for research and refinement to introduce better-personalized cancer drug sensitivity testing and other possible applications into the market.

pexels-gustavo-fring-4149044.jpg